Mirabella Financial Services LLP Uni Qure N.V. Transaction History

Mirabella Financial Services LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$18.7 - $23.07 $281,304 - $347,042	-15,043 Reduced 22.04%	53,198 $1.07 Million
Q4 2022 Feb 13, 2023	BUY	$18.12 - $27.32 $1.24 Million - $1.86 Million	68,241 New	68,241 $1.55 Million
Q4 2020 Feb 16, 2021	SELL	$35.35 - $50.67 $349,328 - $500,720	-9,882 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$35.98 - $47.66 $355,554 - $470,976	9,882 New	9,882 $364,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.